Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 396.95
+9.75 (2.52%)
Jul 23, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Biosimilars | 88.18B | Log In | Log In | Log In | Log In | Upgrade |
Biosimilars Growth | 58.61% | Log In | Log In | Log In | Log In | Upgrade |
Research | 34.37B | Log In | Log In | Log In | Log In | Upgrade |
Research Growth | 9.50% | Log In | Log In | Log In | Log In | Upgrade |
Generics | 25.00B | Log In | Log In | Log In | Log In | Upgrade |
Generics Growth | 1.80% | Log In | Log In | Log In | Log In | Upgrade |
Novels | - | Log In | Log In | Log In | Log In | Upgrade |
Novels Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Biologics | - | Log In | Log In | Log In | Log In | Upgrade |
Biologics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Branded Formulations | - | Log In | Log In | Log In | Log In | Upgrade |
Branded Formulations Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
United States | 64.55B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 55.80% | Log In | Log In | Log In | Log In | Upgrade |
European Union (Including Ireland) | 35.17B | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 31.76B | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Growth | -24.01% | Log In | Log In | Log In | Log In | Upgrade |
India | 16.08B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | -3.93% | Log In | Log In | Log In | Log In | Upgrade |
Ireland | - | Log In | Log In | Log In | Log In | Upgrade |
Ireland Growth | - | Log In | Log In | Log In | Log In | Upgrade |